I am writing to you today to bring attention to abuses surrounding the 340B Drug Pricing Program and ask for your help in protecting patients– our family members, friends, and neighbors. The federal 340B program was designed to help low-income and uninsured patients access the care and medications they need to manage conditions such as cancer, HIV, and arthritis. Unfortunately, the 340B program today lacks the level of oversight and transparency that is needed to ensure that savings from reduced drug prices are actually being passed down to needy patients. I urge you to take action to bring greater oversight and transparency to the 340B Drug Pricing Program to ensure patients are actually benefiting from the savings. Please act to ensure hospitals in the program are being held accountable for passing prescription drug discounts on to patients who rely on charity care to maintain their health.

I am writing to bring attention to abuses surrounding the 340B Drug Pricing Program and ask for your help in protecting patients. The 340B Program allows qualifying hospitals and clinics to purchase prescription drugs at a significant discount and pass those discounts on to vulnerable and qualifying patients. Unfortunately, without any legal or regulatory obligation to pass savings on to patients, there is no way to know if patients are benefiting from those drug discounts. Today, evidence suggests that qualifying hospitals and clinics may be abusing the 340B program and harming patients in the process. 340B program sales grew over 400% from 2012 to 2019 without a proportionate increase in-patient treatment access, indicating that 340B hospitals, clinics, and pharmacies are profiting at the expense of patients. Please ensure hospitals in the program are being held accountable for passing prescription drug discounts to patients who rely on charity care to maintain their health.